Dexchlorpheniramine Maleate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09555 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 52 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acute intermittent porphyria | KG + DL |
| 2 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 3 | porphyria | KG + DL |
| 4 | schizophrenia | KG + DL |
| 5 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 6 | allergic urticaria | KG + DL |
| 7 | syndromic myopia | KG + DL |
| 8 | atypical glycine encephalopathy | KG + DL |
| 9 | myopia 26, X-linked, female-limited | KG + DL |
| 10 | myopia X-linked | KG + DL |
| 11 | hydranencephaly (disease) | KG + DL |
| 12 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 13 | headache disorder | KG + DL |
| 14 | retinal dystrophy with or without extraocular anomalies | KG + DL |
| 15 | primary hereditary glaucoma | KG + DL |
| 16 | trigeminal autonomic cephalalgia | KG + DL |
| 17 | open-angle glaucoma | KG + DL |
| 18 | erythropoietic uroporphyria associated with myeloid malignancy | KG + DL |
| 19 | cold urticaria | KG + DL |
| 20 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 21 | hereditary photodermatosis | KG + DL |
| 22 | common cold | KG + DL |
| 23 | hypertrichosis (disease) | KG + DL |
| 24 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 25 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 26 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 27 | isolated genetic hair shaft abnormality | KG + DL |
| 28 | glaucoma 1, open angle | KG + DL |
| 29 | lissencephaly | KG + DL |
| 30 | hereditary late onset Parkinson disease | KG + DL |
| 31 | subarachnoid hemorrhage (disease) | KG + DL |
| 32 | chronic tic disorder | KG + DL |
| 33 | psychogenic movement disorders | KG + DL |
| 34 | coronary artery disease | KG + DL |
| 35 | benign shuddering attacks | KG + DL |
| 36 | extrapyramidal and movement disease | KG + DL |
| 37 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 38 | atypical juvenile parkinsonism | KG + DL |
| 39 | primary orthostatic tremor | KG + DL |
| 40 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 41 | lingual-facial-buccal dyskinesia | KG + DL |
| 42 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 43 | hereditary coproporphyria | KG + DL |
| 44 | juvenile onset Parkinson disease 19A | KG + DL |
| 45 | nasal cavity disease | KG + DL |
| 46 | bronchial disease | KG + DL |
| 47 | myocardial ischemia | KG + DL |
| 48 | nephrogenic diabetes insipidus | KG + DL |
| 49 | PLA2G6-associated neurodegeneration | KG + DL |
| 50 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
(Showing top 50 of 52 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.